United Guardian Inc (UG)

$6.15 -0.02 (-0.32%)
Market Cap 28.35M
Revenue (ttm) 12.18M
Net Income (ttm) 3.25M
EPS (ttm) N/A
PE Ratio 14.28
Forward PE N/A
Profit Margin 26.68%
Debt to Equity Ratio 0.00
Volume 3,700
Avg Vol 6,924
Day's Range N/A - N/A
Shares Out 4.59M
Stochastic %K 10%
Beta 0.96
Analysts Strong Buy
Price Target N/A

Company Profile

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as so...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 631 273 0900
Fax: 631 273 0858
Website: u-g.com
Address:
230 Marcus Boulevard, P.O. Box 18050, Hauppauge, United States
fer69
fer69 Nov. 12 at 5:40 PM
$AESI on my watchlist to buy … at these levels looks like a nice entry. Also added more to my position on $UG growth sector .. nice dividend yield after reducing it with low payout ratio .. great ROI and EPS .. no debt and big insider ownership.. micro cap ( very volatile ) w great support around $6.10 … easy doubling money here if you hold for at least 1 year + dividends
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 7:08 PM
$UG drops 10% after weak Q3 — is the shine fading? 💄📉 Cosmetics sales dragged earnings lower year over year, squeezing margins, even as pharma and medical segments showed growth. Full breakdown of what drove the drop 👉 https://www.zacks.com/stock/news/2789573/ug-q3-profit-falls-yy-on-weak-cosmetics-sales-stock-declines-10?cid=sm-stocktwits-2-2789573-teaser-20584&ADID=SYND_STOCKTWITS_TWEET_2_2789573_TEASER_20584
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 6:08 PM
$UG down 10% post-earnings — is it all doom and gloom? 🤔 📉 Q3 sales fell 26%, cosmetics hit hard by geopolitical issues 💊 Pharma and medical segments up 10% and 6% for the first nine months of 2025 🔄 Strategic moves in sexual wellness & Renacidin expansion offer hope Opportunity or risk? Full breakdown here 👉 https://www.zacks.com/stock/news/2789573/ug-q3-profit-falls-yy-on-weak-cosmetics-sales-stock-declines-10?cid=sm-stocktwits-2-2789573-body-20585&ADID=SYND_STOCKTWITS_TWEET_2_2789573_BODY_20585
0 · Reply
d_risk
d_risk Nov. 6 at 4:19 PM
$UG - United-Guardian Inc. Common Stock - 10Q - Updated Risk Factors UG’s updated risk factors highlight extended uncertainty from US-China tariff talks, ongoing distributor negotiations, and a longer nine-month impact timeline, though supply chain exposure to China remains limited. #USChinaTariffs #NineMonthImpact #ExtendedUncertainty #SupplyChainRisk #DistributorNegotiations 🟢 Added 🟠 Removed https://d-risk.ai/UG/10-Q/2025-11-06
0 · Reply
Italia95
Italia95 Sep. 18 at 4:35 PM
$UG United-Guardian: A Growth Stock Mispriced as a Cash Cow stock (cash cow), while the underlying business has pivoted toward reinvestment-driven compounding. United-Guardian enjoys a durable moat—supported by specialized know-how, high margins, and niche dominance in personal care and medical formulations—which, according to Buffett-style frameworks, ensures the business can redeploy capital at attractive rates for at least the next decade. In essence, the market is mispricing quality with growth optionality. While investors continue to value UG on the basis of past dividend streams, the reinvestment strategy in premium products could meaningfully expand earnings power. If successful, this shift should justify a re-rating of the stock closer to a growth multiple, rather than the current “income stock” discount. This disconnect between perception and reality offers a compelling opportunity for long-term investors willing to look beyond Mr. Market’s outdated view of United-Guardian.
0 · Reply
Italia95
Italia95 Sep. 18 at 4:33 PM
$UG United-Guardian: A Growth Stock Mispriced as a Cash Cow At present, Mr. Market continues to value United-Guardian, Inc. (UG) as a cash cow—a mature, dividend-paying business with limited growth prospects. This perception is rooted in the company’s historical strategy of distributing the majority of its earnings as dividends to shareholders, reinforcing the narrative of stability but little expansion. However, under the leadership of CEO Donna Vigilante, a fundamental strategic shift is underway. Rather than continuing the traditional high-payout policy, management has deliberately chosen to reinvest earnings into the company’s premium product portfolio—most notably Renacidil and other specialized formulations. This transition signals a move away from a “harvest” model toward a growth-focused capital allocation policy. For discerning investors, this creates a classic case of market inefficiency. Mr. Market is still applying a valuation multiple consistent with a no-growth, income
0 · Reply
Italia95
Italia95 Sep. 13 at 2:31 PM
$UG United-Guardian’s moat is built on its highly specialized niche in healthcare and personal care formulations, particularly products like Renacidin and its proprietary cosmetic ingredients. The company benefits from strong regulatory barriers, long-standing relationships with hospitals and distributors, and high switching costs for customers who rely on its proven safety and effectiveness. Its brand reputation, combined with the difficulty for competitors to replicate formulations and approvals, creates a durable competitive edge. These factors make the moat sustainable for well over 10 years, as new entrants would face both scientific and regulatory hurdles before gaining meaningful market share.
0 · Reply
Italia95
Italia95 Sep. 13 at 1:57 PM
$UG The decision by CEO Donna Vigilante to cut the dividend and reinvest in United-Guardian marks a bold and forward-looking shift in strategy. Instead of maintaining the company as a classic “cash cow,” she is redirecting resources to fuel innovation, expansion, and long-term value creation. This move signals a transformation from a steady income play into a true growth stock. While some investors may initially view a reduced dividend as a drawback, the reinvestment of capital into high-return opportunities has the potential to compound shareholder value far beyond what a static payout could deliver. It’s a strategic pivot that shows leadership with vision — positioning United-Guardian for sustainable growth over the next decade.
0 · Reply
fer69
fer69 Sep. 13 at 1:35 PM
$UG loading here on Monday with the money I got from my $6 calls assigned on $SBSW on Friday … this is a great solid company w strong balance sheet , no debt , started to grow again and big insider ownership .. add the 7% yield on dividends (high payout around 90%) so there is a risk of a cut but long track of paying dividends .. has 100% upside potential
0 · Reply
Italia95
Italia95 Sep. 12 at 11:40 AM
$UG $UG United Guardian At these prices $UG looks like a true Buffett-style bargain: niche business, sky-high margins, and a moat that has lasted for decades thanks to very high switching costs. Cosmetic and pharma companies don’t reformulate easily – it would mean re-certifications, clinical studies, and risking consumer trust. The new CEO is taking a more vigilant approach: cost optimization, stronger push into international markets, and revitalizing legacy products with new partnerships. This isn’t a hype-driven story – it’s about solid cash flows, outstanding returns on capital, and reliable dividends. A microcap with a moat that easily lasts 10+ years. Exactly the kind of stock young Buffett would have bought and locked away.
0 · Reply
Latest News on UG
United-Guardian Reports Third Quarter Earnings

Nov 6, 2025, 9:00 AM EST - 8 days ago

United-Guardian Reports Third Quarter Earnings

United-Guardian Reports Second Quarter Results

Aug 8, 2025, 9:00 AM EDT - 3 months ago

United-Guardian Reports Second Quarter Results

United-Guardian Reports 2024 Financial Results

Mar 21, 2025, 9:00 AM EDT - 8 months ago

United-Guardian Reports 2024 Financial Results

United-Guardian Declares Cash Dividend

Jan 30, 2025, 9:00 AM EST - 10 months ago

United-Guardian Declares Cash Dividend

Top 3 Defensive Stocks You'll Regret Missing In November

Dec 1, 2024, 12:48 AM EST - 1 year ago

Top 3 Defensive Stocks You'll Regret Missing In November

BUD

United-Guardian Reports Increased Third Quarter Earnings

Nov 8, 2024, 9:00 AM EST - 1 year ago

United-Guardian Reports Increased Third Quarter Earnings

United-Guardian Reports Increased Second Quarter Sales & Earnings

Aug 9, 2024, 9:00 AM EDT - 1 year ago

United-Guardian Reports Increased Second Quarter Sales & Earnings

Wall Street Set To Tumble As Macro Concerns Return, VIX Spikes And Global Markets Sell Off: Safe-Haven Gold Rises To Record High As Traders Eye July Jobs Data

Aug 2, 2024, 8:01 AM EDT - 1 year ago

Wall Street Set To Tumble As Macro Concerns Return, VIX Spikes And Global Markets Sell Off: Safe-Haven Gold Rises To Record High As Traders Eye July Jobs Data

AAAU DGP GLD GLDM IAU OUNZ

United-Guardian Announces Dividend Increase

Jul 12, 2024, 9:00 AM EDT - 1 year ago

United-Guardian Announces Dividend Increase

Gold Rises Sharply; Methode Electronics Shares Spike Higher

Jul 11, 2024, 2:35 PM EDT - 1 year ago

Gold Rises Sharply; Methode Electronics Shares Spike Higher

AAAU DGP GLD GLDM IAU MEI OUNZ

Gold Rises 1%; Accenture Shares Surge After Q3 Results

Jun 20, 2024, 12:00 PM EDT - 1 year ago

Gold Rises 1%; Accenture Shares Surge After Q3 Results

AAAU ACN DGP GLD GLDM IAU OUNZ

United-Guardian Reports Increased First Quarter Sales & Earnings

May 10, 2024, 3:00 PM EDT - 1 year ago

United-Guardian Reports Increased First Quarter Sales & Earnings

Gold rises, oil choppy after Iran attacks Israel

Apr 14, 2024, 7:58 PM EDT - 1 year ago

Gold rises, oil choppy after Iran attacks Israel

AAAU DGP GLD GLDM IAU OUNZ

United-Guardian Reports 2023 Financial Results

Mar 22, 2024, 9:00 AM EDT - 1 year ago

United-Guardian Reports 2023 Financial Results

Gold rises above $2,100 to highest level ever as traders bet on interest rate cuts

Mar 4, 2024, 6:08 PM EST - 1 year ago

Gold rises above $2,100 to highest level ever as traders bet on interest rate cuts

AAAU DGP GLD GLDM IAU OUNZ

United-Guardian: Solid Balance Sheet, Solid Dividend, Strong Potential Upside

Feb 20, 2024, 4:51 AM EST - 1 year ago

United-Guardian: Solid Balance Sheet, Solid Dividend, Strong Potential Upside

Strategic Reversal: Gold Rises to Five-Day High, Signals Strength

Jan 12, 2024, 4:20 PM EST - 2 years ago

Strategic Reversal: Gold Rises to Five-Day High, Signals Strength

AAAU DGP GLD GLDM IAU OUNZ

Gold, Silver, Copper Daily Forecast: Gold Rises to $2,032, Silver and Copper Navigate Market Volatility

Jan 9, 2024, 9:04 AM EST - 2 years ago

Gold, Silver, Copper Daily Forecast: Gold Rises to $2,032, Silver and Copper Navigate Market Volatility

AAAU DGP GLD GLDM IAU OUNZ

United-Guardian Appoints New Director

Jan 8, 2024, 9:00 AM EST - 2 years ago

United-Guardian Appoints New Director

Gold rises to 6-month-high driven by weaker dollar

Nov 27, 2023, 10:16 AM EST - 2 years ago

Gold rises to 6-month-high driven by weaker dollar

AAAU DGP GLD GLDM IAU OUNZ

United-Guardian Reports Increased Third Quarter Sales & Earnings

Nov 6, 2023, 9:00 AM EST - 2 years ago

United-Guardian Reports Increased Third Quarter Sales & Earnings

Gold rises, on track for back-to-back gains following four-week losing streak

Aug 21, 2023, 8:17 AM EDT - 2 years ago

Gold rises, on track for back-to-back gains following four-week losing streak

AAAU DGP GLD GLDM IAU OUNZ

United-Guardian Reports Second Quarter Financial Results

Aug 11, 2023, 9:00 AM EDT - 2 years ago

United-Guardian Reports Second Quarter Financial Results

United-Guardian Announces Mid-Year Dividend

Jul 14, 2023, 9:00 AM EDT - 2 years ago

United-Guardian Announces Mid-Year Dividend

United-Guardian: A High-Risk/High-Reward Investment

Jul 7, 2023, 6:22 PM EDT - 2 years ago

United-Guardian: A High-Risk/High-Reward Investment

United-Guardian Appoints New President

Jun 13, 2023, 3:00 PM EDT - 2 years ago

United-Guardian Appoints New President

United-Guardian Reports First Quarter Financial Results

May 11, 2023, 10:00 AM EDT - 2 years ago

United-Guardian Reports First Quarter Financial Results

Gold rises above $2,000 amid UBS's Credit Suisse rescue

Mar 20, 2023, 11:09 AM EDT - 2 years ago

Gold rises above $2,000 amid UBS's Credit Suisse rescue

AAAU DGP GLD GLDM IAU OUNZ UBS

United-Guardian Reports 2022 Financial Results

Mar 17, 2023, 9:00 AM EDT - 2 years ago

United-Guardian Reports 2022 Financial Results

United-Guardian's Business Is Under Threat, And The Stock Is Still Expensive

Jan 19, 2023, 10:46 AM EST - 3 years ago

United-Guardian's Business Is Under Threat, And The Stock Is Still Expensive

United-Guardian Declares Year-End Dividend

Nov 21, 2022, 9:00 AM EST - 3 years ago

United-Guardian Declares Year-End Dividend

United-Guardian Reports Third Quarter Financial Results

Nov 9, 2022, 9:00 AM EST - 3 years ago

United-Guardian Reports Third Quarter Financial Results

United-Guardian Announces Appointment of New President & CEO

Oct 25, 2022, 10:00 AM EDT - 3 years ago

United-Guardian Announces Appointment of New President & CEO

Gold rises for third day as dollar, Treasury yields pull back

Aug 25, 2022, 7:32 AM EDT - 3 years ago

Gold rises for third day as dollar, Treasury yields pull back

AAAU DGP GLD GLDM IAU OUNZ

United-Guardian Reports Second Quarter Financial Results

Aug 12, 2022, 10:00 AM EDT - 3 years ago

United-Guardian Reports Second Quarter Financial Results

Gold rises for second day, bolstered by dollar's pullback

Jul 19, 2022, 8:07 AM EDT - 3 years ago

Gold rises for second day, bolstered by dollar's pullback

AAAU DGP GLD GLDM IAU OUNZ

Gold rises as European inflation data undermines dollar

Jun 29, 2022, 9:10 AM EDT - 3 years ago

Gold rises as European inflation data undermines dollar

AAAU DGP GLD GLDM IAU OUNZ

United-Guardian Completes Review of Strategic Alternatives; Announces Retirement of the Company's CEO

Jun 14, 2022, 10:00 AM EDT - 3 years ago

United-Guardian Completes Review of Strategic Alternatives; Announces Retirement of the Company's CEO

United-Guardian Reports First Quarter Financial Results and Dividend Payment

May 12, 2022, 9:00 AM EDT - 3 years ago

United-Guardian Reports First Quarter Financial Results and Dividend Payment

Gold Rises as Investors Seeking an Inflation Haven Pour Into Gold ETFs

May 6, 2022, 12:37 PM EDT - 3 years ago

Gold Rises as Investors Seeking an Inflation Haven Pour Into Gold ETFs

AAAU DGP GLD GLDM IAU OUNZ

fer69
fer69 Nov. 12 at 5:40 PM
$AESI on my watchlist to buy … at these levels looks like a nice entry. Also added more to my position on $UG growth sector .. nice dividend yield after reducing it with low payout ratio .. great ROI and EPS .. no debt and big insider ownership.. micro cap ( very volatile ) w great support around $6.10 … easy doubling money here if you hold for at least 1 year + dividends
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 7:08 PM
$UG drops 10% after weak Q3 — is the shine fading? 💄📉 Cosmetics sales dragged earnings lower year over year, squeezing margins, even as pharma and medical segments showed growth. Full breakdown of what drove the drop 👉 https://www.zacks.com/stock/news/2789573/ug-q3-profit-falls-yy-on-weak-cosmetics-sales-stock-declines-10?cid=sm-stocktwits-2-2789573-teaser-20584&ADID=SYND_STOCKTWITS_TWEET_2_2789573_TEASER_20584
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 6:08 PM
$UG down 10% post-earnings — is it all doom and gloom? 🤔 📉 Q3 sales fell 26%, cosmetics hit hard by geopolitical issues 💊 Pharma and medical segments up 10% and 6% for the first nine months of 2025 🔄 Strategic moves in sexual wellness & Renacidin expansion offer hope Opportunity or risk? Full breakdown here 👉 https://www.zacks.com/stock/news/2789573/ug-q3-profit-falls-yy-on-weak-cosmetics-sales-stock-declines-10?cid=sm-stocktwits-2-2789573-body-20585&ADID=SYND_STOCKTWITS_TWEET_2_2789573_BODY_20585
0 · Reply
d_risk
d_risk Nov. 6 at 4:19 PM
$UG - United-Guardian Inc. Common Stock - 10Q - Updated Risk Factors UG’s updated risk factors highlight extended uncertainty from US-China tariff talks, ongoing distributor negotiations, and a longer nine-month impact timeline, though supply chain exposure to China remains limited. #USChinaTariffs #NineMonthImpact #ExtendedUncertainty #SupplyChainRisk #DistributorNegotiations 🟢 Added 🟠 Removed https://d-risk.ai/UG/10-Q/2025-11-06
0 · Reply
Italia95
Italia95 Sep. 18 at 4:35 PM
$UG United-Guardian: A Growth Stock Mispriced as a Cash Cow stock (cash cow), while the underlying business has pivoted toward reinvestment-driven compounding. United-Guardian enjoys a durable moat—supported by specialized know-how, high margins, and niche dominance in personal care and medical formulations—which, according to Buffett-style frameworks, ensures the business can redeploy capital at attractive rates for at least the next decade. In essence, the market is mispricing quality with growth optionality. While investors continue to value UG on the basis of past dividend streams, the reinvestment strategy in premium products could meaningfully expand earnings power. If successful, this shift should justify a re-rating of the stock closer to a growth multiple, rather than the current “income stock” discount. This disconnect between perception and reality offers a compelling opportunity for long-term investors willing to look beyond Mr. Market’s outdated view of United-Guardian.
0 · Reply
Italia95
Italia95 Sep. 18 at 4:33 PM
$UG United-Guardian: A Growth Stock Mispriced as a Cash Cow At present, Mr. Market continues to value United-Guardian, Inc. (UG) as a cash cow—a mature, dividend-paying business with limited growth prospects. This perception is rooted in the company’s historical strategy of distributing the majority of its earnings as dividends to shareholders, reinforcing the narrative of stability but little expansion. However, under the leadership of CEO Donna Vigilante, a fundamental strategic shift is underway. Rather than continuing the traditional high-payout policy, management has deliberately chosen to reinvest earnings into the company’s premium product portfolio—most notably Renacidil and other specialized formulations. This transition signals a move away from a “harvest” model toward a growth-focused capital allocation policy. For discerning investors, this creates a classic case of market inefficiency. Mr. Market is still applying a valuation multiple consistent with a no-growth, income
0 · Reply
Italia95
Italia95 Sep. 13 at 2:31 PM
$UG United-Guardian’s moat is built on its highly specialized niche in healthcare and personal care formulations, particularly products like Renacidin and its proprietary cosmetic ingredients. The company benefits from strong regulatory barriers, long-standing relationships with hospitals and distributors, and high switching costs for customers who rely on its proven safety and effectiveness. Its brand reputation, combined with the difficulty for competitors to replicate formulations and approvals, creates a durable competitive edge. These factors make the moat sustainable for well over 10 years, as new entrants would face both scientific and regulatory hurdles before gaining meaningful market share.
0 · Reply
Italia95
Italia95 Sep. 13 at 1:57 PM
$UG The decision by CEO Donna Vigilante to cut the dividend and reinvest in United-Guardian marks a bold and forward-looking shift in strategy. Instead of maintaining the company as a classic “cash cow,” she is redirecting resources to fuel innovation, expansion, and long-term value creation. This move signals a transformation from a steady income play into a true growth stock. While some investors may initially view a reduced dividend as a drawback, the reinvestment of capital into high-return opportunities has the potential to compound shareholder value far beyond what a static payout could deliver. It’s a strategic pivot that shows leadership with vision — positioning United-Guardian for sustainable growth over the next decade.
0 · Reply
fer69
fer69 Sep. 13 at 1:35 PM
$UG loading here on Monday with the money I got from my $6 calls assigned on $SBSW on Friday … this is a great solid company w strong balance sheet , no debt , started to grow again and big insider ownership .. add the 7% yield on dividends (high payout around 90%) so there is a risk of a cut but long track of paying dividends .. has 100% upside potential
0 · Reply
Italia95
Italia95 Sep. 12 at 11:40 AM
$UG $UG United Guardian At these prices $UG looks like a true Buffett-style bargain: niche business, sky-high margins, and a moat that has lasted for decades thanks to very high switching costs. Cosmetic and pharma companies don’t reformulate easily – it would mean re-certifications, clinical studies, and risking consumer trust. The new CEO is taking a more vigilant approach: cost optimization, stronger push into international markets, and revitalizing legacy products with new partnerships. This isn’t a hype-driven story – it’s about solid cash flows, outstanding returns on capital, and reliable dividends. A microcap with a moat that easily lasts 10+ years. Exactly the kind of stock young Buffett would have bought and locked away.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 1:18 PM
$UG Great piece that accurately captures UG's current position. So if you want to refresh your understanding of UG or learn about UG for the first time, this is essential reading. https://beyondspx.com/quote/UG/united-guardian-s-specialized-chemistry-a-niche-powerhouse-adapting-to-global-shifts-nasdaq-ug#analysis
0 · Reply
Italia95
Italia95 Aug. 27 at 9:17 PM
$UG
0 · Reply
Italia95
Italia95 Aug. 21 at 1:02 PM
$UG anyone following this stock? It looks undervalued
2 · Reply
ZacksResearch
ZacksResearch Aug. 14 at 4:08 PM
$UG Q2 drop — but is a rebound brewing? Earnings fell year over year as cosmetic sales lagged, though gains in pharma and medical lubricants offered some cushion. Recovery hopes are still on the table. Full breakdown here 👉 https://www.zacks.com/stock/news/2712764/ug-q2-earnings-fall-yy-on-weak-cosmetic-sales-pharma-gains?cid=sm-stocktwits-2-2712764-teaser-7903&ADID=SYND_STOCKTWITS_TWEET_2_2712764_TEASER_7903
0 · Reply
ZacksResearch
ZacksResearch Aug. 14 at 3:08 PM
Is $UG's cosmetic sales slump a buying opportunity? 🤔 Despite a 34.5% drop in net income YoY, management is optimistic about resolving ASI’s overstock issue and separately boosting Renacidin sales through new formularies. Discover if United-Guardian can bounce back here 👉 https://www.zacks.com/stock/news/2712764/ug-q2-earnings-fall-yy-on-weak-cosmetic-sales-pharma-gains?cid=sm-stocktwits-2-2712764-body-7904&ADID=SYND_STOCKTWITS_TWEET_2_2712764_BODY_7904
0 · Reply
d_risk
d_risk Aug. 8 at 2:48 PM
$UG - United-Guardian Inc. Common Stock - 10Q - Updated Risk Factors UG flags new risks from global supply chain instability, inflation, and tariffs, warning these could disrupt operations and pressure margins in 2025. #Pharmaceuticals #MarginPressure #Tariffs #InflationImpact #SupplyChainRisk 🟢 Added 🟠 Removed https://d-risk.ai/UG/10-Q/2025-08-08
0 · Reply
Bigboy0206
Bigboy0206 Jul. 24 at 6:54 AM
$UG
0 · Reply
Larry57486
Larry57486 Jul. 17 at 4:56 AM
$YFI.X $UG @Larry57486
0 · Reply
LewisDaKat
LewisDaKat Jul. 15 at 7:25 PM
News out United Guardian Inc. (NASDAQ: UG) Making Surprising Moves in Tuesday Session https://marketwirenews.com/news-releases/united-guardian-inc-nasdaq-ug-making-surprising-move-6734874295846351.html $UG
0 · Reply
Watson42
Watson42 May. 16 at 6:14 AM
$PG $CL $IFF $UG Please clean your portfolio. (Sunshine Cleaning, Movie 2008) $SPY
0 · Reply
PenkeTrading
PenkeTrading Apr. 15 at 1:59 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of United-Guardian Inc. Is that bullish or bearish? $UG #RsiOversold #NASDAQ
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 25 at 12:50 AM
$UG Digging UG's strategic pivot. Cosmetic ingredients showing serious growth. Natrajel line could be a game-changer. Watching closely for Q1 2025 performance. Potential long-term play. well-written article: https://beyondspx.com/article/united-guardian-inc-nasdaq-ug-a-versatile-player-navigating-the-evolving-landscapes-of-cosmetics-pharmaceuticals-and-beyond
1 · Reply